This expert-led course, backed by Dr. Hussain Al-Zubaidi, offers practical insights into GLP-1 medications, helping fitness and wellness professionals understand their impact on weight management and how they integrate into a broader approach to training and lifestyle coaching.
Provider - Future Fit Training
Professional standard endorsed against - Working with People with Long Term Conditions
Assessment - 10-question multiple-choice assessment with a 70% pass mark
CPD points – 2.5
In terms of structure, this CPD opportunity offers three distinct levels of learning: foundational knowledge, advanced insights into GLP-1 mechanisms, and practical applications through real-world case studies.
GLP-1 is a hormone critical in regulating appetite, metabolism, and blood sugar level.
GLP-1 agonists, or GLP-1 receptor agonists, are a type of weight-loss drug that helps to suppress appetite.
On 15 October 2024, the Health Secretary, Wes Streeting, announced the rollout of GLP-1 agonist medication to help get people back into work as a measure to address the severest forms of obesity across the UK.
The ‘eligible population’ amounts to millions, and though not everyone will be offered the drug, it is expected to be taken up by a large number of the population.
As interest in GLP-1 therapies grows, staying well-informed will allow you to support clients in making confident, informed decisions about their fitness and well-being. It’s also essential for fitness professionals to understand their effects on exercise and nutrition.
Take a look at our how we are collaborating with ukactive to aid the sector’s understanding of pharmacological treatments used for weight loss.
Individual and collective professional recognition for the sport and physical activity workforce.
